Researchers are reportedly “encouraged” by the results of a new COVID-19 test kit, reports NH Business Review.
Recently, a team at Dartmouth-Hitchcock Medical Center in Lebanon has been conducting a 20-sample pilot study, which aims to evaluate the accuracy and performance of a new COVID-19 test kit being manufactured by Sherlock Biosciences.
Sherlock Biosciences is a Cambridge, Massachusetts-based engineering biology company.
According to William J. Blake, the company’s chief technology office, “Results from this pilot study have demonstrated – in real patient samples – that our CRISPR-based diagnostic test accurately reports the presence or absence of the COVID-19.”
This test kit, which recently received Emergency Use Authorization from the US Food and Drug Administration, is currently the only CRISPR-based diagnostic test to receive approval to date. The test is reportedly designed to be a faster alternative to the current testing protocols.
WNTK Local News 